Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.

Cancer Res

Authors' Affiliations: Department of Pediatrics; Cancer Genomics Project, Graduate School of Medicine; Laboratory of DNA Information Analysis and Sequence Data Analysis, Human Genome Center, Institute of Medical Science; Department of Cell Therapy and Transplantation Medicine, The University of Tokyo, Tokyo; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto; Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Ibaraki; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Saitama; Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka; Gunma Children's Medical Center, Shibukawa, Gunma; Department of Hematology and Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo; and National Center for Child Health and Development, Tokyo, Japan

Published: May 2014

Pleuropulmonary blastoma (PPB) is a rare pediatric malignancy whose pathogens are poorly understood. Recent reports suggest that germline mutations in the microRNA-processing enzyme DICER1 may contribute to PPB development. To investigate the genetic basis of this cancer, we performed whole-exome sequencing or targeted deep sequencing of multiple cases of PPB. We found biallelic DICER1 mutations to be very common, more common than TP53 mutations also found in many tumors. Somatic ribonuclease III (RNase IIIb) domain mutations were identified in all evaluable cases, either in the presence or absence of nonsense/frameshift mutations. Most cases had mutated DICER1 alleles in the germline with or without an additional somatic mutation in the remaining allele, whereas other cases displayed somatic mutations exclusively where the RNase IIIb domain was invariably affected. Our results highlight the role of RNase IIIb domain mutations in DICER1 along with TP53 inactivation in PPB pathogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2470DOI Listing

Publication Analysis

Top Keywords

rnase iiib
12
iiib domain
12
biallelic dicer1
8
mutations
8
dicer1 mutations
8
pleuropulmonary blastoma
8
domain mutations
8
mutations sporadic
4
sporadic pleuropulmonary
4
blastoma pleuropulmonary
4

Similar Publications

Exomic and epigenomic analysis of pulmonary blastoma.

Lung Cancer

September 2024

Cancer Axis, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada. Electronic address:

Objective: Pulmonary blastoma is a rare, biphasic, adult-onset lung tumor. In this study, we investigate whether DICER1 pathogenic variants are a feature of pulmonary blastomas through in-depth analysis of the molecular events defining them.

Methods: We performed exome-wide sequencing and DNA methylation profiling of 8 pulmonary blastomas from 6 affected persons.

View Article and Find Full Text PDF

Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.

Gynecol Oncol

July 2024

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA; International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA; Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA. Electronic address:

Objective: Sertoli-Leydig cell tumors (SLCTs) are rare sex cord-stromal tumors, representing <0.5% of all ovarian tumors. We sought to describe prognostic factors, treatment and outcomes for individuals with ovarian SLCT.

View Article and Find Full Text PDF

Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.

Diagn Pathol

April 2024

Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.

Background: Müllerian adenosarcoma, a rare malignancy, presents diagnostic and therapeutic challenges. In this study, we conducted an analysis of the clinicopathological characteristics of 22 adenosarcomas, with a particular focus on screening for DICER1 hot mutations.

Methods: The cohort consisted of patients with adenosarcoma who were registered at the West China Second Hospital between the years 2020 and June 2022.

View Article and Find Full Text PDF
Article Synopsis
  • DICER1 tumor predisposition syndrome can cause different types of tumors, especially in kids.
  • A child had a rare tumor called an extraskeletal chondroma in their toe and had a specific type of DICER1 gene change, different from what is usually found.
  • This gene change messes up the process of making molecules that help control genes, showing that there are other ways the DICER1 gene can cause problems without completely stopping it from working.
View Article and Find Full Text PDF

Germline pathogenic loss-of-function (pLOF) variants in are associated with a predisposition for a variety of solid neoplasms, including pleuropulmonary blastoma and Sertoli-Leydig cell tumor (SLCT). The most common pLOF variants include small insertions or deletions leading to frameshifts, and base substitutions leading to nonsense codons or altered splice sites. Larger deletions and pathogenic missense variants occur less frequently.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!